Brooks Laboratories Limited discloses termination of the proposed composite scheme of arrangement involving its joint venture Brooks Steriscience Limited.
BSL's Board decided not to pursue the transaction in its current form after deliberation, citing the best interest of all stakeholders.
This update follows the in-principle approval received from NSE and BSE for the scheme on February 6, 2026.